跳至主要内容
临床试验/EUCTR2015-002366-23-AT
EUCTR2015-002366-23-AT
进行中(未招募)
1 期

Goal-directed heart rate control during emergence from anesthesia using esmolol to attenuate myocardial injury in patients undergoing non-cardiac surgery

Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management0 个研究点目标入组 140 人2015年8月27日

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
myocardial damage
发起方
Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management
入组人数
140
状态
进行中(未招募)
最后更新
7年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2015年8月27日
结束日期
待定
最后更新
7年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management

入排标准

入选标准

  • \= 45 years
  • scheduled for elective major non\-cardiac surgery
  • general anesthesia (using general anesthetic drug(s) and opioids)
  • anticipated postoperative hospital stay for \> 2 days
  • no treatment with ß\-receptor blocking drugs for more than 30 days
  • increased cardiovascular risk because of history of coronary artery disease or a combination of \= 2 of the following risk factors: \= 70 years, congestive heart failure (NYHA \= II), chronic renal failure, smoking history, hypertension, diabetes, lipid\-lowering drug treatment or hypercholesterolemia, and obesity (BMI \> 35\).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 50

排除标准

  • patients who do not understand the informed consent
  • spinal or epidural anesthesia
  • history of ischemic cerebrovascular disease
  • severe asthma and COPD
  • preoperative heart rate \<61 beats per minute (bpm)
  • cardiac pacemaker
  • atrioventricular block type 2 and 3
  • sick sinus syndrome
  • sinoatrial block
  • cardiogenic shock

结局指标

主要结局

未指定

相似试验